Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
15-12G - Newcourt Acquisition Corp (0001849475) (Filer)
8-K - Newcourt Acquisition Corp (0001849475) (Filer)
25-NSE - Newcourt Acquisition Corp (0001849475) (Subject)
4 - Newcourt Acquisition Corp (0001849475) (Issuer)
4 - Newcourt Acquisition Corp (0001849475) (Issuer)
3 - Newcourt Acquisition Corp (0001849475) (Issuer)
NEW YORK, NY, Jan. 22, 2024 (GLOBE NEWSWIRE) -- Newcourt Acquisition Corp ("Newcourt") (NASDAQ:NCAC) announced today that the conditions to closing the business combination (the "Business Combination") pursuant to the Amended and Restated Business Combination Agreement, dated July 31, 2023 (as amended, supplemented, or otherwise modified from time to time, the "Amended and Restated Business Combination Agreement"), by and among Newcourt, Newcourt SPAC Sponsor LLC, Psyence Group Inc. (CSE:PSYG) ("Psyence"), Psyence Biomedical Ltd., a corporation organized under the laws of Ontario, Canada ("Pubco"), Psyence (Cayman) Merger Sub, Psyence Biomed Corp., and Psyence Biomed II Corp. have not yet
New York, NY, Dec. 30, 2022 (GLOBE NEWSWIRE) -- Newcourt Acquisition Corp (the "Company") (NASDAQ:NCAC) announced today that the Company has determined to modify the terms of the proposed amendment (the "Trust Agreement Amendment") of the Company's investment management trust agreement, dated as of October 19, 2021 (the "Trust Agreement"), described in the Company's definitive proxy statement (the "Definitive Proxy Statement") filed on December 21, 2022 for the solicitation of proxies in connection with an extraordinary general meeting of the Company's shareholders to be held on January 6, 2023 to consider and vote on the extension (the "Extension") of the time period the Company has to co
SC 13G/A - Newcourt Acquisition Corp (0001849475) (Subject)
SC 13G/A - Newcourt Acquisition Corp (0001849475) (Subject)
SC 13D/A - Newcourt Acquisition Corp (0001849475) (Subject)